TELA Bio, Inc. (TELA) Q1 2025 Earnings Call Transcript
TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Louisa…
Bio Protocol’s Massive Upgrade Brings AI and Blockchain to Research Funding
TL;DR Bio Protocol has launched the Bio V1 update, which uses artificial intelligence and blockchain to transform the…
Gene Therapy-Focused Bluebird Bio Receives Rival Takeover Offer, Stock Jumps – bluebird bio (NASDAQ:BLUE)
Bluebird Bio, Inc. BLUE received an unsolicited, non-binding written proposal from Ayrmid Ltd. on Friday. Ayrmid has proposed…
Korro Bio: Promising Early Stage RNA Editing Company (NASDAQ:KRRO)
This article was written by Follow Avisol Capital Partners is made up of a team of medical experts,…
Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio In $286M Deal
Bristol Myers Squibb is acquiring 2seventy bio, a deal that gives the pharmaceutical giant full control over the…
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity
Bluebird Bio, a company that steered three gene therapies to FDA approval but struggled to commercialize them, has…
Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape – Third Harmonic Bio (NASDAQ:THRD)
On Tuesday, Third Harmonic Bio, Inc. THRD revealed results from its Phase 1 single and multiple ascending dose…
BIO, SONIC, SWARMS and VINE are available for trading!
We’re thrilled to announce that BIO, SONIC, SWARMS and VINE are now available for trading on Kraken! Funding…
Next Cryptocurrency to Explode, 29 January — Wormhole, dogwifhat, Jito, Bio Protocol
Join Our Telegram channel to stay up to date on breaking news coverage The overall feeling in the…
Mubadala-backed Kelix Bio seals MENA insulin manufacturing deal
Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Investment (Mubadala), has completed the acquisition of insulin…